ממנטין
הערות שוליים

↑  Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006
1 2  Areosa SA, Sherriff F, McShane R (2005). "Memantine for dementia". Cochrane Database Syst Rev (3): CD003154. doi:10.1002/14651858.CD003154.pub4. PMID 16034889.{{cite journal}}:  תחזוקה - ציטוט: multiple names: authors list (link)
↑  Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006.
↑  Joint Formulary Committee (2004). British National Formulary (47th ed.). London: BMA and the Royal Pharmaceutical Society of Great Britain. ISBN 0-85369-584-9.
↑  אוניפארם בע״מ, ת.ד. 21429, ת״א, 6121301, עלון לצרכן - ממוקס, באתר מאגר התרופות - משרד הבריאות, ‏11/2021
↑  Parsons CG, Stöffler A, Danysz W (בנובמבר  2007). "Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system — too little activation is bad, too much is even worse". Neuropharmacology. 53 (6): 699–723. doi:10.1016/j.neuropharm.2007.07.013. PMID 17904591. {{cite journal}}:  (עזרה)תחזוקה - ציטוט: multiple names: authors list (link)
↑  Rammes G, Rupprecht R, Ferrari U, Zieglgänsberger W, Parsons CG (ביוני  2001). "The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner". Neurosci Lett. 306 (1–2): 81–4. doi:10.1016/S0304-3940(01)01872-9. PMID 11403963. {{cite journal}}:  (עזרה)תחזוקה - ציטוט: multiple names: authors list (link)
↑  Chen HS, Lipton SA (ביוני  2006). "The chemical biology of clinically tolerated NMDA receptor antagonists". J Neurochem. 97 (6): 1611–26. doi:10.1111/j.1471-4159.2006.03991.x. PMID 16805772. {{cite journal}}:  (עזרה)
↑  Buisson B, Bertrand D (1 במרץ 1998). "Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor". Mol Pharmacol. 53 (3): 555–63. PMID 9495824. {{cite journal}}:  (עזרה)
↑  Aracava Y, Pereira EF, Maelicke A, Albuquerque EX (במרץ  2005). "Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons". J Pharmacol Exp Ther. 312 (3): 1195–205. doi:10.1124/jpet.104.077172. PMID 15522999. {{cite journal}}:  (עזרה)תחזוקה - ציטוט: multiple names: authors list (link)
↑  Seeman P, Caruso C, Lasaga M (בפברואר  2008). "Memantine agonist action at dopamine D2High receptors". Synapse. 62 (2): 149–53. doi:10.1002/syn.20472. PMID 18000814. {{cite journal}}:  (עזרה)תחזוקה - ציטוט: multiple names: authors list (link)
↑  כפי שמצוטט באינדקס מרק Merck Index
↑  Francis, P.T., Altered Glutamate Neurotransmission and Behaviour in Dementia: Evidence from Studies of Memantine
Current Molecular Pharmacology, 2009. 2( 77): p. 77-82.
↑  Clive G. Ballard, S.G., Jeffrey L. Cummings, Henry Brodaty, George T. Grossberg, Philippe Robert and Constantine G. Lyketsos, Management of agitation and aggression associated with Alzheimer disease. nature reviews | neurology 2009. volume 5 p. 245-255.
↑  Ian D Maidment, C.G.F., Malaz Boustani, Jorge Rodriguez, Ruth C Brown, and Cornelius L Katona, Efficacy of Memantine on Behavioral and Psychological Symptoms Related to Dementia: A Systematic Meta-Analysis. The Annals of Pharmacotherapy 2008 Volume 42: p. 32-38.
↑  Lon S. Schneider, M.D., Pierre N. Tariot, M.D., Karen S. Dagerman, M.S., Sonia M. Davis, Dr.P.H.,, et al., Effectiveness of Atypical Antipsychotic Drugs
In Patients with Alzheimer’s Disease. The New England Journal of Mdicine, 2006. 15(355): p. 1525-1538.
↑  P. Borghammer1, M.V., K. Ostergaard2, A. Rodell1,C. Bailey3, P. Cumming3, Effect of memantine on CBF and CMRO2 in patients with early Parkinson's disease. Acta Neurol Scand  2008. 117: p. 317–323.
↑  Patrizia Mecocci1*, A.B.m.a.K.S., Effects of memantine on cognition in patients with moderate to severe Alzheimer’s disease: post-hoc analyses of
ADAS-cog and SIB total and single-item scores from six  randomized, double-blind, placebo-controlled studies. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2009. 24: p. 532–538.
↑  S Ferris1, P.R., B Winblad3, G Gatz4, G Michailov4, S Gauthier5, Assessment of Memantine Treatment Effects on Language
↑  Frederick A. Schmitt, P., * Christopher H. van Dyck, MD,w Christine H. Wichems, PhD,z and Jason T. Olin, PhD,y; for the Memantine MEM-MD-02 Study Group, Cognitive Response to Memantine in Moderate to Severe Alzheimer Disease Patients Already Receiving Donepezil - An Exploratory Reanalysis. Alzheimer Dis Assoc Disorders, 2006 Volume 20,(Number 4): p. 255-262.
↑  Oscar L Lopez, J.T.B., Abdus Whahed, Judith A Saxton, Robert Sweet, Dr  David Wolk, William Klunk and Steven T DeKosky, Memantine augments the effects of cholinesterase inhibition in the treatment of Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 2009.
| --- | --- |
בקרת זהויות :  BNE: XX552194 
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.